CAMBRIDGE, Mass.
(Map)
-
CAMBRIDGE, Mass., April 4, 2008 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management
will present an overview of its Hepatitis C program at the upcoming Canaccord
Adams Hepatitis C Conference on Wednesday, April 9, 2008 at 1:30 p.m. ET at
the St. Regis Hotel in New York, NY.
The live and archived webcast of the company presentation can be accessed
under "Calendar of Events" in the Idenix Investor Center at www.idenix.com.
Please log in approximately 5-10 minutes before each event to ensure a timely
connection. The archived replays will be available on the Idenix website for
two weeks following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,
is a biopharmaceutical company engaged in the discovery and development of
drugs for the treatment of human viral and other infectious diseases.
Idenix's current focus is on the treatment of infections caused by the
hepatitis C virus and HIV. For further information about Idenix, please refer
to http://www.idenix.com.
Idenix Pharmaceuticals' Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
